6533b85bfe1ef96bd12ba999

RESEARCH PRODUCT

Stellenwert der Skelettszintigraphie in der Diagnostik und Verlaufskontrolle des Ewing-Sarkoms

Manfred ThelenEissner DT. SchaubChristoph DüberAntoniadis AGutjahr PGreinacher I

subject

Pathologymedicine.medical_specialtyResponse to therapymedicine.diagnostic_testbusiness.industryRadiographymedicine.diseaseScintigraphyTumor recurrenceBone lesionmedicineRadiology Nuclear Medicine and imagingIn patientSarcomaNuclear medicinebusinessPerfusion

description

The radiological and scintigraphic findings of 26 patients with histologically proven Ewing's sarcoma were analysed. Three-phase bone scan should be done early in patients presenting with pain and normal radiographs. Perfusion and metabolism of a bone lesion can be assessed by skeletal scintigraphy. Bone metastases are first seen on bone scan. In the follow-up of the patient bone scans at regular intervals are essential to detect bone metastases and tumour recurrence. The scintigraphic findings have to be correlated with radiographs and if these are negative a short-term control is indicated. Three-phase bone scans can assess the tumours response to therapy.

https://doi.org/10.1055/s-2008-1047045